Answers are grounded in this paper and cite their sources.
High-dimensional cellular phenotypes can motivate biological hypotheses, but similarity alone cannot establish mechanism or causal validity. DISCOVERY-AGENT links exploratory JUMP Cell Painting evidence with evidence-grounded hypothesis generation, independent critique and bounded human-review routing. An initial 65-record CRISPR/ORF analysis across nine gene–modality tests found four FDR-significant CRISPR plate-level associations (AKT1, BRCA1, MTOR and TP53), none among evaluated ORF genes. A distinct later cross-source compound-identity benchmark used 614 morphological features and achieved AUROC 0.6142 on 1,250 held-out compounds with training-only preprocessing; this is identity discrimination, not mechanism-of-action classification. Three structured hypotheses underwent LLM critique and revision, while eleven gene-pair evidence assessments yielded no FDR-significant mechanistic finding (minimum q = 0.2037). Archived governance checks passed 1,021/1,021 predefined tests; nevertheless, the initial live-agent run contained two execution errors among five cases, with both cases responding on fresh retest. These findings demonstrate feasibility of auditable evidence processing and modest cross-source morphology signal, not validated autonomous discovery, prospective safety, or completed expert review. The work delineates practical requirements for independent biological validation and reproducible scientific agents.
No takes yet. Share an insight, caveat, or question.
Kamran et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: